Cancer of the Prostate Clinical Trials in Cleveland, Ohio
2 recruitingCleveland, Ohio
Showing 1–2 of 2 trials
Recruiting
Phase 3
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Prostate CancerCancer of the ProstateHormone Sensitive Prostate Cancer+1 more
Pfizer1,000 enrolled295 locationsNCT07028853
Recruiting
Not Applicable
Investigation of Impact of AI on Prostate Cancer Workflow
Prostate CancerProstatic NeoplasmCancer of the Prostate+1 more
Case Comprehensive Cancer Center150 enrolled1 locationNCT07084779